MODGENE LLC has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are SHANGHAI INST OF LIFE SCIENCES, RALPH STEPHEN JOHN and CZERNIECKI BRIAN J.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | Hong Kong | 2 | |
#6 | Mexico | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | China | 1 | |
#9 | Hungary | 1 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Hilbush Brian S | 20 |
#2 | Sutcliffe J Gregor | 20 |
#3 | Bloom Floyd E | 12 |
#4 | Hedlund Peter B | 3 |
#5 | Floyd E Bloom | 1 |
#6 | Brian S Hilbush | 1 |
#7 | J Gregor Sutcliffe | 1 |
Publication | Filing date | Title |
---|---|---|
AU2014200956A1 | Modification of amyloid-beta load in non-brain tissue | |
EP2776035A1 | Compositions and methods for reduction of amyloid-beta load | |
HUE027027T2 | Reduction of amyloid-beta load in non-brain tissue | |
US2010150944A1 | Methods and compositions for diagnosis and treatment of depression and anxiety |